Abbott India Ltd.

NSE: ABBOTINDIA · Healthcare

₹26,345.00-0.98%06 Nov 2026

Ask the data

Instant answers about Abbott India Ltd. — computed from its filings, no language model

Market cap₹55,983 cr

Current price₹26,345.00

High / Low₹30,205 / ₹25,030

P/E34.7

P/B—

Book value—

ROE—

ROCE—

Debt / equity—

Dividend yield—

EPS (TTM)₹759.85

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 15 periods

	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†	FY20†	FY21†	FY22†	FY23†	FY24†	FY25†	FY26†
Revenue	1,531	1,696	1,877	2,290	2,628	2,939	3,316	3,679	4,093	4,310	4,919	5,353	5,849	6,409	6,929
EBITDA	174	218	222	312	367	397	533	605	756	921	1,088	1,210	1,453	1,695	1,892
Operating margin	11.4%	12.9%	11.8%	13.6%	13.9%	13.5%	16.1%	16.4%	18.5%	21.4%	22.1%	22.6%	24.8%	26.4%	27.3%
Interest	—	—	0	0	1	2	4	2	9	18	19	16	12	11	25
Depreciation	18	19	17	15	14	16	16	17	60	58	66	70	71	72	76
Profit before tax	188	223	248	344	402	436	622	699	803	926	1,080	1,274	1,618	1,887	2,079
Tax	63	74	81	115	142	160	220	249	210	235	281	324	417	473	527
Net profit	125	149	167	229	260	277	401	450	593	691	799	949	1,201	1,414	1,552

Quarterly performance

last 72 quarters · ₹ crore

showing latest 8 of 72 periods

	FEB '08†	MAY '08†	AUG '08†	FEB '09†	MAY '09†	AUG '09†	FEB '10†	MAY '10†	AUG '10†	NOV '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†	JUN '19†	SEP '19†	DEC '19†	MAR '20†	JUN '20†	SEP '20†	DEC '20†	MAR '21†	JUN '21†	SEP '21†	DEC '21†	MAR '22†	JUN '22†	SEP '22†	DEC '22†	MAR '23†	JUN '23†	SEP '23†	DEC '23†	MAR '24†	JUN '24†	SEP '24†	DEC '24†	MAR '25†	JUN '25†	SEP '25†	DEC '25†	MAR '26†	JUN '26†
Revenue	148	168	181	169	197	205	206	229	255	277	242	358	410	386	376	412	417	448	420	440	457	486	494	527	589	574	601	633	645	667	683	738	729	756	715	715	931	881	788	845	980	948	906	999	1,055	1,078	961	1,064	1,055	1,095	1,096	1,218	1,222	1,224	1,255	1,304	1,379	1,326	1,343	1,479	1,494	1,437	1,439	1,558	1,633	1,614	1,605	1,738	1,757	1,724	1,710	1,814
Operating profit	18	19	26	22	28	34	19	22	37	39	9	26	64	55	29	44	55	73	46	42	65	64	50	70	88	86	68	96	86	102	82	105	106	123	63	62	201	163	107	111	194	146	153	174	204	240	138	233	241	242	206	265	260	269	294	270	343	316	280	355	381	388	330	391	439	436	429	446	502	463	481	522
Operating margin	12.4%	11.2%	14.6%	12.9%	14.3%	16.7%	9.4%	9.7%	14.4%	14.2%	3.6%	7.3%	15.5%	14.3%	7.8%	10.8%	13.2%	16.3%	10.9%	9.6%	14.3%	13.2%	10.2%	13.3%	14.9%	15.0%	11.3%	15.1%	13.4%	15.3%	12.1%	14.3%	14.5%	16.3%	8.8%	8.6%	21.6%	18.5%	13.5%	13.2%	19.8%	15.5%	16.9%	17.4%	19.4%	22.2%	14.4%	21.9%	22.8%	22.1%	18.8%	21.8%	21.3%	22.0%	23.4%	20.7%	24.9%	23.9%	20.9%	24.0%	25.5%	27.0%	22.9%	25.1%	26.9%	27.0%	26.7%	25.6%	28.6%	26.9%	28.1%	28.8%
Other income	4	7	3	3	1	1	1	1	2	2	3	5	5	5	5	6	6	6	6	7	7	19	9	10	12	13	14	12	13	12	13	14	14	14	15	16	15	19	59	22	25	38	29	30	29	28	28	28	22	15	16	19	18	19	21	26	34	40	50	56	56	56	81	67	60	72	76	73	70	70	76	75
Interest	—	—	0	0	—	0	0	—	—	—	0	—	—	0	0	0	—	—	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	1	1	2	1	1	0	1	2	2	2	3	4	5	4	5	5	5	4	5	4	4	4	4	3	3	3	3	3	2	2	4	6	8	5	6	6
Depreciation	1	2	2	2	2	2	2	2	3	3	3	3	4	5	6	4	5	5	5	5	4	4	3	3	4	4	3	3	3	4	4	4	4	4	4	4	4	4	4	4	4	4	5	15	15	15	15	14	14	15	15	16	16	17	17	17	17	18	17	17	18	18	18	18	18	18	18	19	19	19	19	20
Profit before tax	21	25	27	22	27	33	18	21	36	38	9	28	65	56	39	46	56	74	47	44	68	79	56	76	96	95	78	105	96	111	90	115	116	133	72	73	212	178	159	129	214	180	177	187	216	251	149	242	244	238	202	264	257	267	292	275	355	335	308	390	415	422	390	437	479	488	483	493	546	509	531	572
Tax	7	7	10	8	10	11	7	7	12	13	3	11	21	19	12	17	18	24	15	15	23	25	18	25	32	30	28	36	34	41	31	41	41	47	30	25	74	62	59	46	76	63	63	70	38	64	38	62	63	61	49	68	65	67	81	70	90	88	77	100	102	111	103	109	121	127	116	127	131	133	136	144
Net profit	14	18	18	14	18	22	12	14	24	26	6	17	44	37	27	30	38	50	32	30	45	53	38	51	64	65	50	69	62	70	59	74	75	86	42	48	138	115	100	82	138	117	113	117	178	187	111	180	181	177	152	196	192	199	211	206	266	247	231	290	313	311	287	328	359	361	367	366	415	376	395	429
EPS ₹	9.78	12.56	12.14	10.29	12.85	16.24	8.63	10.29	17.47	18.67	4.34	12.50	20.53	17.36	12.75	13.89	18.04	23.42	14.92	13.98	21.27	25.16	18.07	23.97	30.00	30.37	23.42	32.26	29.04	33.11	27.77	34.83	35.30	40.26	19.79	22.71	64.72	54.30	47.10	38.78	64.79	55.08	53.28	55.03	83.92	87.85	52.22	84.87	85.05	83.36	71.75	92.12	90.51	93.74	99.49	96.77	124.95	116.16	108.90	136.58	147.27	146.34	135.09	154.36	168.76	169.78	0.00	0.00	0.00	0.00	0.00	0.00
Revenue YoY	—	—	—	—	17.0%	13.7%	21.6%	16.2%	24.1%	—	—	—	—	—	55.2%	14.9%	1.6%	16.0%	11.6%	6.9%	9.6%	8.6%	17.6%	19.8%	28.9%	17.9%	21.7%	20.1%	9.6%	16.3%	13.7%	16.6%	13.1%	13.3%	4.8%	-3.2%	27.6%	16.6%	10.2%	18.2%	5.2%	7.5%	15.0%	18.2%	7.7%	13.8%	6.1%	6.5%	0.0%	1.6%	14.0%	14.4%	15.9%	11.8%	14.6%	7.1%	12.9%	8.3%	7.0%	13.4%	8.3%	8.3%	7.1%	5.3%	9.3%	12.3%	11.5%	11.6%	7.6%	6.8%	6.5%	4.3%
Profit YoY	—	—	—	—	-3.2%	26.4%	-16.1%	-20.0%	7.6%	—	—	—	—	—	355.9%	72.6%	-12.1%	35.0%	17.1%	0.6%	17.9%	7.4%	21.1%	71.4%	41.0%	20.7%	29.6%	34.6%	-3.2%	9.0%	18.6%	7.9%	21.6%	21.6%	-28.7%	-34.8%	83.3%	34.9%	137.9%	70.8%	0.1%	1.4%	13.1%	41.9%	29.5%	59.5%	-2.0%	54.2%	1.3%	-5.1%	37.4%	8.5%	6.4%	12.5%	38.7%	5.0%	38.1%	23.9%	9.5%	41.1%	17.9%	26.0%	24.0%	13.0%	14.6%	16.0%	27.9%	11.5%	15.8%	4.2%	7.6%	17.1%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 60 periods

	NOV '10	DEC '11	MAR '12	JUN '12	SEP '12	DEC '12	MAR '13	JUN '13	SEP '13	DEC '13	MAR '14	JUN '14	SEP '14	DEC '14	MAR '15	JUN '15	SEP '15	DEC '15	MAR '16	JUN '16	SEP '16	DEC '16	MAR '17	JUN '17	SEP '17	DEC '17	MAR '18	JUN '18	SEP '18	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
Net margin	7.8%	7.4%	8.1%	8.7%	8.3%	8.8%	8.8%	8.7%	8.9%	8.9%	8.9%	9.6%	9.9%	10.0%	10.0%	10.3%	10.0%	9.8%	9.9%	9.7%	9.9%	10.1%	9.4%	8.6%	10.1%	10.6%	12.1%	12.6%	12.5%	12.3%	12.2%	12.7%	13.4%	14.7%	14.5%	15.8%	15.8%	15.5%	16.0%	15.8%	15.5%	15.5%	16.2%	16.2%	17.1%	17.7%	17.7%	18.7%	19.2%	19.9%	20.5%	20.9%	21.2%	21.4%	22.1%	22.0%	22.5%	22.3%	22.4%	23.1%
EBITDA margin	12.2%	11.0%	11.4%	12.2%	11.6%	12.2%	12.9%	12.5%	12.8%	12.1%	11.8%	12.7%	13.0%	13.5%	13.6%	14.1%	13.7%	13.8%	13.9%	13.8%	14.0%	14.3%	13.5%	12.1%	14.4%	15.1%	16.1%	16.9%	16.5%	15.7%	16.4%	17.4%	17.3%	19.1%	18.5%	19.6%	20.5%	20.5%	21.4%	21.4%	21.0%	21.0%	22.1%	21.8%	22.8%	23.2%	22.6%	23.4%	23.6%	24.4%	24.8%	25.1%	25.5%	25.6%	26.4%	26.5%	27.0%	27.0%	27.3%	28.1%
Interest coverage	—	—	—	—	—	—	—	—	—	3406.00	3537.00	5587.60	6139.80	6460.40	689.72	718.35	406.16	401.88	496.96	516.05	1082.95	1337.74	214.97	156.89	158.53	149.18	163.70	175.93	179.73	184.15	310.23	204.01	152.00	129.54	95.10	79.38	64.63	54.33	51.63	51.16	52.64	53.90	57.53	60.70	68.05	74.46	80.66	92.93	102.55	113.56	130.94	141.34	154.92	174.83	166.09	134.99	103.78	90.19	84.20	87.06

Balance sheet

equity vs borrowings over time · ₹ crore

Not filed yet.

Cash flow

annual · ₹ crore · line = free cash flow

Not filed yet.

Where the assets sit

No balance sheet filed yet.

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Abbott India Ltd.	55,983	26,345.00	34.7	—	—

StoxGud checklist: Neutral setup · 5/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+1.0%

6 months-1.3%

1 year-11.3%

3Y CAGR+4.2%

5Y CAGR+5.6%

10Y CAGR+18.8%

50-day avg₹26,150.00

200-day avg₹26,616.58

RSI (14)52

Compare Abbott India Ltd. with

Alkem Laboratories vs Abbott India Biocon vs Abbott India Fortis Healthcare vs Abbott India Abbott India vs Gland Pharma Abbott India vs Anthem Biosciences Abbott India vs Ipca Laboratories

FAQs

What is the share price of Abbott India Ltd.?

Abbott India Ltd. (ABBOTINDIA) closed at ₹26,345.00 on NSE on 06 Nov 2026.

What is the market cap of Abbott India Ltd.?

₹55,983 crore at the latest close.

What is the P/E ratio of Abbott India Ltd.?

34.7, on trailing-twelve-month earnings from its filings.

How fast is Abbott India Ltd. growing?

Abbott India Ltd.: revenue has compounded at 9.0% a year over three years; net profit at 17.8% a year. Latest-quarter revenue is up 4.3% year on year, profit up 17.1%.

How profitable is Abbott India Ltd.?

On a trailing-twelve-month basis operating margin 28.1%, net margin 23.1%.

How much debt does Abbott India Ltd. have?

Debt to equity isn't meaningful for Abbott India Ltd. (banks borrow as part of their business) or isn't filed yet.

Abbott India Ltd.'s results are not in NSE's XBRL filings, so these are its standalone quarterly results as published on BSE (†), ₹ crore, from FEB '08; full years are summed from the quarters. No balance sheet or cash flow is available from this source. Information only, not investment advice.